1. Welcome! Pathways and Targets: How do these affect my treatment options? Part of Fight Colorectal Cancer’s Monthly Patient Webinar Series Our webinar will begin shortly…

1. Neurologic effects of cancertreatment Survivorship conference 2013 2. introduction• The arc of medical advance – Supportive care – Crude but sometimes effective…

Slide 1 Statistical Issues in Incorporating and Testing Biomarkers in Phase III Clinical Trials FDA/Industry Workshop; September 29, 2006 Daniel Sargent, PhD Sumithra Mandrekar,…

Slide 1 Analgesic clinical trials and their assay sensitivity Robert H. Dworkin, PhD Professor of Anesthesiology, Neurology, Oncology, and Psychiatry Professor, Center for…

Activity endpoints in soft tissue sarcoma phase II trials Quality and correlations Activity endpoints in soft tissue sarcoma phase II trials Quality and correlations with…

Novel Targets and Therapies for GI Malignancies: What does the future hold? David H. Ilson, M.D., Ph.D. GI Oncology Service Memorial Sloan-Kettering Cancer Center New York,…

Statistical Issues in Incorporating and Testing Biomarkers in Phase III Clinical Trials FDA/Industry Workshop; September 29, 2006 Daniel Sargent, PhD Sumithra Mandrekar,…

Activity endpoints in soft tissue sarcoma phase II trials Quality and correlations Activity endpoints in soft tissue sarcoma phase II trials Quality and correlations with…

The only certainties seemed to be uncertainties as the 11th Congress of the World Federation of Societies of Intensive and Critical Care Medicine drew to a close. For both…